0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA | 
Research Letter | 
Jolanda C. Kuijvenhoven, MD; Daniël A. Korevaar, MD; Kurt G. Tournoy, MD, PhD; et al.
JAMA. 2016;316(10):1110-1112. doi:10.1001/jama.2016.10349.
Includes: Supplemental Content

JAMA Oncology | 
Research Letter | 
Amanda J. Redig, MD, PhD; Daniel B. Costa, MD, PhD; Myriam Taibi, BA; et al.
JAMA Oncol. 2016;2(9):1240-1242. doi:10.1001/jamaoncol.2016.1304.
Includes: Supplemental Content

JAMA Oncology | 
Review | 
Adrian G. Sacher, MD; Leena Gandhi, MD, PhD
JAMA Oncol. 2016;2(9):1217-1222. doi:10.1001/jamaoncol.2016.0639.

JAMA Oncology | 
Brief Report |  ONLINE FIRST
Patricia Gaule, PhD; James W. Smithy, BS; Maria Toki, MD; et al.
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.3015
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Mizuki Nishino, MD, MPH; Anita Giobbie-Hurder, MS; Hiroto Hatabu, MD, PhD; et al.
JAMA Oncol. Published online August 18, 2016. doi:10.1001/jamaoncol.2016.2453
Includes: Supplemental Content

JAMA Oncology | 
Brief Report | 
Daniel E. Spratt, MD; Tiffany Chan, MA; Levi Waldron, PhD; et al.
JAMA Oncol. 2016;2(8):1070-1074. doi:10.1001/jamaoncol.2016.1854.

JAMA Dermatology | 
Observation | 
Jun Young Seong, MD; Sook Hyun Kong, MD; Yu Sung Choi, MD, PhD; et al.
JAMA Dermatol. 2016;152(8):947-948. doi:10.1001/jamadermatol.2016.1098.

JAMA Oncology | 
Editorial | 
P. Mickey Williams, PhD; Barbara A. Conley, MD
JAMA Oncol. 2016;2(8):1003-1005. doi:10.1001/jamaoncol.2016.0240.

JAMA Oncology | 
Original Investigation | 
Adrian G. Sacher, MD; Cloud Paweletz, PhD; Suzanne E. Dahlberg, PhD; et al.
JAMA Oncol. 2016;2(8):1014-1022. doi:10.1001/jamaoncol.2016.0173.
Includes: Supplemental Content

JAMA Oncology | 
JAMA Oncology Clinical Evidence Synopsis |  ONLINE FIRST
Fábio Nasser Santos, MD; Marcelo Rocha Souza Cruz, MD; Rachel Riera, MD, MSC, PhD
JAMA Oncol. Published online July 28, 2016. doi:10.1001/jamaoncol.2016.2050

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA
Research Letter  | 
Five-Year Survival After Endosonography vs Mediastinoscopy for Mediastinal Nodal Staging of Lung Cancer
Jolanda C. Kuijvenhoven, MD; Daniël A. Korevaar, MD; Kurt G. Tournoy, MD, PhD; et al.
JAMA Oncology
Review  | 
Biomarkers for the Clinical Use of PD-1/PD-L1 Inhibitors in Non–Small-Cell Lung Cancer A Review
Adrian G. Sacher, MD; Leena Gandhi, MD, PhD
JAMA Oncology
Research Letter  | 
Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 Trial
Amanda J. Redig, MD, PhD; Daniel B. Costa, MD, PhD; Myriam Taibi, BA; et al.
JAMA Oncology
Brief Report  | 
A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1
Patricia Gaule, PhD; James W. Smithy, BS; Maria Toki, MD; et al.